Randomised double blind trial to evaluate prevention of breast cancer using tamoxifen in high risk women

http://isrctn.org/> ◽

10.1186/isrctn07027313 ◽

2012 ◽

Author(s):

Trevor Powles

Keyword(s):

Breast Cancer ◽

High Risk ◽

Double Blind Trial ◽

Double Blind ◽

Blind Trial ◽

High Risk Women ◽

Prevention Of Breast Cancer

Download Full-text

Faculty Opinions recommendation of Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718206879.793509584 ◽

2015 ◽

Author(s):

Pagona Lagiou

Keyword(s):

Breast Cancer ◽

High Risk ◽

Postmenopausal Women ◽

Controlled Trial ◽

Double Blind ◽

Prevention Of Breast Cancer

Download Full-text

Effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: a randomized, controlled, double-blind trial

Lipids in Health and Disease ◽

10.1186/s12944-015-0100-8 ◽

2015 ◽

Vol 14 (1) ◽

Author(s):

Richard L. Dunbar ◽

Stephen J. Nicholls ◽

Kevin C. Maki ◽

Eli M. Roth ◽

David G. Orloff ◽

...

Keyword(s):

Cardiovascular Risk ◽

High Risk ◽

Carboxylic Acids ◽

Risk Markers ◽

Double Blind Trial ◽

Omega 3 ◽

Double Blind ◽

Blind Trial ◽

Lipoprotein Particles ◽

Randomized Controlled

Download Full-text

Preliminary Results of a Placebo-Controlled, Double-Blind Trial Evaluating Sequential HD-AraC/Mitoxantrone Induction Chemotherapy with or Without Granulocyte-Macrophage Colony-Stimulating Factor in Patients with High-Risk Myelodysplastic Syndromes

Acute Leukemias VI - Haematology and Blood Transfusion / Hämatologie und Bluttransfusion ◽

10.1007/978-3-642-60377-8_141 ◽

1997 ◽

pp. 908-911

Author(s):

W. Verbeek ◽

B. Wörmann ◽

P. Koch ◽

C. Aul ◽

H. Hinrichs ◽

...

Keyword(s):

High Risk ◽

Myelodysplastic Syndromes ◽

Double Blind Trial ◽

Colony Stimulating Factor ◽

Double Blind ◽

Blind Trial ◽

Preliminary Results ◽

Macrophage Colony Stimulating Factor ◽

Macrophage Colony ◽

Stimulating Factor

Download Full-text

PP-8-3 Double-blind trial in postmenopausal (PMP) women with advanced breast cancer (ABC) showing a dose-effect and superiority of 2.5 mg letrozole over megestrol acetate (MA)

European Journal of Cancer ◽

10.1016/0959-8049(96)84236-5 ◽

1996 ◽

Vol 32 ◽

pp. 49 ◽

Author(s):

I. Smith ◽

P. Dombemowsky ◽

G. Falkson ◽

R. Leonard ◽

L. Panasci ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Advanced Breast ◽

Megestrol Acetate ◽

Dose Effect ◽

Double Blind Trial ◽

Double Blind ◽

Download Full-text

Abstract P4-15-06: Results of a randomized double blind trial of neoadjuvant anastrozole plus placebo vs anastrozole plus saracatinib for ER+ postmenopausal breast cancer

10.1158/1538-7445.sabcs18-p4-15-06 ◽

2019 ◽

Author(s):

JM Slingerland ◽

P Mark ◽

J Hurley ◽

J Net ◽

F Collado-Mesa ◽

...

Keyword(s):

Breast Cancer ◽

Postmenopausal Breast Cancer ◽

Double Blind Trial ◽

Double Blind ◽

Download Full-text

A randomised double-blind trial in post-menopausal women with primary breast cancer who have received adjuvant tamoxifen for 2-3 years, comparing subsequent adjuvant exemestane treatment with further tamoxifen

http://isrctn.org/> ◽

10.1186/isrctn11883920 ◽

2013 ◽

Author(s):

RE Coleman

Keyword(s):

Breast Cancer ◽

Primary Breast Cancer ◽

Adjuvant Tamoxifen ◽

Double Blind Trial ◽

Double Blind ◽

Blind Trial ◽

Menopausal Women ◽

Post Menopausal

Download Full-text

A randomised double-blind trial comparing arimidex alone with nolvadex alone with arimidex and nolvadex in combination, as adjuvant treatment in post-menopausal women with breast cancer

http://isrctn.org/> ◽

10.1186/isrctn18233230 ◽

2012 ◽

Author(s):

Joan Houghton

Keyword(s):

Breast Cancer ◽

Adjuvant Treatment ◽

Double Blind Trial ◽

Double Blind ◽

Blind Trial ◽

Menopausal Women ◽

Post Menopausal

Download Full-text

A phase 2 prospective, randomized, double-blind trial comparing the effects of tranexamic acid with ecallantide on blood loss from high-risk cardiac surgery with cardiopulmonary bypass (CONSERV-2 Trial)

Journal of Thoracic and Cardiovascular Surgery ◽

10.1016/j.jtcvs.2011.06.001 ◽

2012 ◽

Vol 143 (5) ◽

pp. 1022-1029 ◽

Author(s):

Paula M. Bokesch ◽

Gabor Szabo ◽

Ryszard Wojdyga ◽

Hilary P. Grocott ◽

Peter K. Smith ◽

...

Keyword(s):

Cardiac Surgery ◽

Cardiopulmonary Bypass ◽

High Risk ◽

Tranexamic Acid ◽

Phase 2 ◽

Double Blind Trial ◽

Double Blind ◽

Download Full-text

Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial

10.1016/s0140-6736(13)62292-8 ◽

2014 ◽

Vol 383 (9922) ◽

pp. 1041-1048 ◽

Author(s):

Jack Cuzick ◽

Ivana Sestak ◽

John F Forbes ◽

Mitch Dowsett ◽

Jill Knox ◽

...

Keyword(s):

Breast Cancer ◽

High Risk ◽

Postmenopausal Women ◽

Controlled Trial ◽

Double Blind ◽

Prevention Of Breast Cancer

Download Full-text

Limitation of the Gail score and mammographic density in recruiting candidate for prevention of breast cancer in high-risk women with precancerous lesions

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.1548 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 1548-1548

Author(s):

D. Rosner ◽

A. Meschcheryakov ◽

V. Bogatyrev ◽

V. Sokolova ◽

A. Hutson ◽

...

Keyword(s):

Breast Cancer ◽

High Risk ◽

Mammographic Density ◽

Precancerous Lesions ◽

High Risk Women ◽

Prevention Of Breast Cancer

Download Full-text